Capital, Competition, & Commercialisation within the CAR & TCR Therapy Landscape

  • Investigating the 2025 trends in CAR and TCR deals and what it means for the space
  • Comparing commercial activity within different disease indications and regions
  • What 2026 may bring in terms of shifting investment and collaborations